The Cancer Letter

Inside information on cancer research and drug development

Vol.
44
No.
18
May 04, 2018May 04, 2018
Free
DOWNLOAD THE PDF
Flatiron, BMS form collaboration to curate regulatory-grade real-world data
Cover Story
Free

Flatiron, BMS form collaboration to curate regulatory-grade real-world data

By Matthew Bin Han Ong
Bristol-Myers Squibb and Flatiron Health announced a three-year collaboration to advance methodologies for the curation of real-world data for cancer research and to develop regulatory-grade information.
BMS's Saha: We're at the start of defining new endpoints, hypotheses with real-world evidence
Conversation with The Cancer LetterFree
By Matthew Bin Han Ong
Oklahoma's Stephenson Cancer Center earns coveted NCI Cancer Center designation
Conversation with The Cancer LetterFree
By Paul Goldberg
New data prompts CDC to examine adequacy of pre-op workup by gynecologists
ClinicalFree
By Matthew Bin Han Ong

NCI Trials

NCI Trials

NCI Trials for May

The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account